Publication | Open Access

Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)

Hematological MalignancyLymphoid NeoplasiaOncologyAltered ExpressionMedicineImmunologyHematologyPharmacotherapyDuvelisib TreatmentApoptotic RegulatorsAdult T-cell Leukemia-lymphomaPharmacology